Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Asian Biomedicine
Volume 4 (2010): Issue 4 (August 2010)
Open Access
Oral fluoropyrimidine-induced severe hyperlipidemia
Bulent Yildiz
Bulent Yildiz
,
Halil Kavgaci
Halil Kavgaci
,
Evren Fidan
Evren Fidan
,
Erdal Gungor
Erdal Gungor
,
Halil O. Ersoz
Halil O. Ersoz
,
Feyyaz Ozdemir
Feyyaz Ozdemir
and
Fazil Aydin
Fazil Aydin
| Apr 13, 2018
Asian Biomedicine
Volume 4 (2010): Issue 4 (August 2010)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Apr 13, 2018
Page range:
627 - 630
DOI:
https://doi.org/10.2478/abm-2010-0079
Keywords
Adverse event
,
capecitabine
,
hypertriglyceridemia
,
oral fluoropyrimidine
,
UFT® drug
© 2018
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Bulent Yildiz
Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University,
Trabzon, Turkey
Halil Kavgaci
Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University,
Trabzon, Turkey
Evren Fidan
Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University,
Trabzon, Turkey
Erdal Gungor
Department of Internal Medicine, Faculty of Medicine, Karadeniz Technical University,
Trabzon, Turkey
Halil O. Ersoz
Department of Endocrinology, Faculty of Medicine, Karadeniz Technical University,
Trabzon, Turkey
Feyyaz Ozdemir
Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University,
Trabzon, Turkey
Fazil Aydin
Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University,
Trabzon, Turkey